-
Monday, 10/11/2021
A new article of SARS-CoV-2 is published in Journal of Internal Medicine.
A new article is published in Journal of Internal Medicine.
The article is entitled: Low anti‐SARS‐CoV‐2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID‐19 patients.
In this article we studied the impact of antiSARS-CoV-2 S antibodies levels on survival, viral RNA-load in plasma, and N-antigenaemia in 92 COVID-19 patients over ICU admission. The corresponding author is Dr Antoni Torres.
-
Tuesday, 09/28/2021
Original Research Article has been published recently on the Critical Care Journal
Original Research Article has been published recently on the Critical Care Journal
The article is entitled: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients.
In this study comparing changes in parameters between day 1 and day 3 of mechanical ventilation in COVID-19 ARDS patients, a higher ventilatory ratio at day 1 and more importantly an increase in the ratio by day 3 were significant predictors of in-hospital mortality. The significance of this finding is not completely understood but might reflect vascular microthrombosis phenomena and/or alveolar edema, factors associated with increased physiologic dead space. The first co-authors are Antoni Torres and Anna Motos.
-
Tuesday, 09/28/2021
Original Research Article has been published recently on the European Respiratory Research Journal.
Original Research Article has been published recently on the European Respiratory Research Journal.
The article is entitled: Prediction of ventilator-associated pneumonia outcomes according to the early microbiological response: a retrospective observational study.This article talks about that follow-up cultures on day 3 after a VAP diagnosis can help the clinician stratify patients. Those patients who present early with superinfection have
worse ICU mortality, worse 90-day mortality and require more days of mechanical
ventilation. The first author is Dr Adrian Ceccato -
Thursday, 09/23/2021
Physiotherapist Nona Rovira joins IAMR group on September 1st 2021
Physiotherapist Nona Rovira joins IAMR group on September 1st 2021
She will focus on the pulmonary rehabilitation in patients with Bronchiectasis non associated to Cystic Fibrosis.
Nona Rovira has joint the research group in order to work on the pulmonary rehabilitation in patients with Bronchiectasis non associated to Cystic Fibrosis (BQ-noFQ).
-
Thursday, 09/16/2021
SEPAR Awards to our researchers
-
Wednesday, 07/14/2021
Thank you to all Data Entry and Monitoring teams who have participated in the Great Research Project: CIBERESUCICOVID
-
Tuesday, 07/06/2021
The 31st European Congress of Clinical Microbiology and Infectious Diseases
Our research group in the Congress
The 31st European Congress of Clinical Microbiology and Infectious Diseases, ECCMID, will be held in July 9-12. Our researchers will participate in it with the following:
Anna Motos, MSc, will present for 10 minutes the Abstract number 3128 entitled: Incidence and characteristics of ventilator-associated pneumonia patients with COVID-19: a multi-center study. July 9th, 15.50h.
The poster of Ruben López. MSc, entilted: The most powerful hypervariable regions of 16S rRNA for taxa identififacion of sputum has been selected as a Highly Rated e-poster, he will be availbale for questions during 20 minutes. July July 9th, 9am.
Dr Alex Soriano will present an Oral Session the poster entilted: Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity matched analysis. July 10th, 17.15h. Dr Catia Cillóniz is one of the authors of this poster.
She has 2 e-poster available during the Congress entilted: “Sepsis in relation to lymphopenia in community-acquired pneumonia” and “The value of C-reactive protein-to-lymphocyte ratio in predicting the severity of SARS Coronavirus 2 (SARS-CoV-2) pneumònia”
Dr Laia Fernández-Barat has an e-poster entilted: “Identification of highly immunogenic epitopes in the SARS-COV-2 Spike protein to produce neutralizing monoclonal antibodies for treatment” available during the Congress.
-
Monday, 07/05/2021
Dr Victoria Alcaraz has received the ERS Young Scientist Sponsorship
-
Monday, 07/05/2021
Patrícia Oscanoa receives the ERS Young Scientist Sponsorhip by the ECCMID
-
Monday, 06/21/2021
Alba Soler joins the IAMR group as a research technician in the study "Human recombinant interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients" - the PREV-HAP study.
Alba Soler holds a degree in Biology from the University of Barcelona since February 2021, mainly focused on molecular, cellular and systems biology. She enrolled the research group in July 2020 to perform her End of Grade Thesis entitled "Bacterial lung chassis for treating biofim-associated human respiratory infections", which obtained the highest scoring "Matrícula d'Honor" and was directed by Dr. Antoni Torres and Dr. Laia Fernandez-Barat. Now is under revision. Alba's End of Grade project is integrated in another project with competitive funding from La Caixa Health Research grants 2018 lead by Prof. Luis Serrano from Center from Genomic Regulation and Prof. Torres from IDIBAPS.
Additionally, during her research internship she has been actively participating in several projects of the group, entering data in the CIBERESUCICOVID study, learning how the microbiological analysis of respiratory samples works in various porcine animal model experiments and performing the microbiological and microbiome analysis of human endotracheal tubes.
From now on, she will also be in charge of the processing of respiratory fluid and blood samples (peripheral blood mononuclear cells, whole blood plasma) from patients progressively included in the PREV-HAP study.
